Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(03): 365-368
DOI: 10.4103/ijmpo.ijmpo_200_17
Original Article

Study of the Use of Traditional, Complementary, and Alternative Medicine in Indian Cancer Patients

Nishitha Shetty
Department of Medical Oncology, Father Muller Medical College and Hospital, Mangalore, Karnataka, India
,
Paraashar Ravindranath Rai
Department of Medical Oncology, Father Muller Medical College and Hospital, Mangalore, Karnataka, India
,
Arpitha Shetty
Department of Medical Oncology, Father Muller Medical College and Hospital, Mangalore, Karnataka, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Objectives: The use of alternative forms of medicine is well known in India, especially amongst cancer patients but there are very few studies that have investigated its usage and benefits. A study was conducted to determine the prevalence of the use of Traditional medicine, Complementary and Alternative Medicine (CAM) by cancer patients visiting a cancer care center. This study laid an emphasis on the predictors of use of CAM. Materials and Methods: This is an observational study conducted from March 2017 to May 2017 at a tertiary cancer care center. After obtaining informed consent, patients were handed a questionnaire and their responses were analyzed. Data analysis tools of Microsoft Office Excel 2007 were used for statistics. Results: A total of 407 patients took part in the study. The prevalence of traditional medicine and CAM was found to be 23.5% (96 patients). The mean duration of CAM use was 4.8 months (0.25 months–48 months). About 77% of the users had an education level below the upper primary level, of which 30.02% were illiterate. About 62.5% of the users were below poverty line. Nearly, 41.7% of the patients had not received any allopathic treatment before starting traditional medicine and CAM and did so for a mean duration of 4 months. About 53% of the patients who received some form of traditional medicine and CAM claim to have experienced some symptomatic benefits from its use. Nearly, 68.75% of the users were simultaneously receiving conventional anticancer therapy. Traditional medicine and CAM use was disclosed to the treating physician by 55% of the patients. Conclusion: Traditional medicine and CAM use have been shown to have a high prevalence among the less-educated and the economically backward sections of the society. There is not sufficient data to support the effectiveness and safety of traditional medicine and CAM. physicians have to acknowledge the increasing incidence of traditional medicine and CAM use in the population and actively inquire and educate the patients on its use.

Keywords

Cancer - complementary and alternative medicine - traditional medicine


Publication History

Received: 27 September 2017

Accepted: 27 April 2018

Article published online:
03 June 2021

© 2019. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 World Health Organization. WHO Traditional Medicine Strategy 2014-2023. 1st ed. World Health Organization; 2017. http://www.apps.who.int/iris/bitstream/10665/92455/1/9789241506090_eng.pdf?ua=1 Available from: [Last accessed on 2017 Jan 12]
    Google Scholar
  • 2 Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ. Complementary and alternative medicine use in oncology: A questionnaire survey of patients and health care professionals. BMC Cancer 2011; 11: 196
    CrossrefPubMedGoogle Scholar
  • 3 Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M. et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol 2005; 23: 2645-54
    CrossrefPubMedGoogle Scholar
  • 4 Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18: 2505-14
    CrossrefPubMedGoogle Scholar
  • 5 Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB. et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000; 18: 2515-21
    CrossrefPubMedGoogle Scholar
  • 6 Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Effects of st. John's wort on irinotecan metabolism. J Natl Cancer Inst 2002; 94: 1247-9
    CrossrefPubMedGoogle Scholar
  • 7 Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: A review of qualitative and quantitative studies. Complement Ther Med 2004; 12: 90-8
    CrossrefPubMedGoogle Scholar
  • 8 Broom A, Nayar K, Tovey P, Shirali R, Thakur R, Seth T. et al. Indian cancer patients' use of traditional, complementary and alternative medicine (TCAM) and delays in presentation to hospital. Oman Med J 2009; 24: 99-102
    PubMedGoogle Scholar
  • 9 Ezzo J, Vickers A, Richardson MA, Allen C, Dibble SL, Issell B. et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol 2005; 23: 7188-98
    CrossrefPubMedGoogle Scholar
  • 10 Taixiang W, Munro AJ, Guanjian L. Chinese medical herbs for chemotherapy side effects in colorectal cancer patients. Cochrane Database Syst Rev 2005; 1: CD004540
    Google Scholar
  • 11 Rahmani AH, Al Zohairy MA, Aly SM, Khan MA. Curcumin: A potential candidate in prevention of cancer via modulation of molecular pathways. Biomed Res Int 2014; 2014: 761608
    CrossrefPubMedGoogle Scholar